In cholecytectomy of cirrhotic patient , fresh frozen plasma should be given
**Core Concept**
The question is testing the concept of managing coagulopathy in a cirrhotic patient undergoing surgery, specifically cholecystectomy. Coagulopathy in cirrhosis is often due to a combination of factors including decreased production of clotting factors by the liver, increased consumption of clotting factors due to chronic liver disease, and platelet dysfunction.
**Why the Correct Answer is Right**
In a cirrhotic patient undergoing surgery, the risk of bleeding is high due to coagulopathy. Fresh frozen plasma (FFP) is used to correct coagulopathy by replenishing clotting factors. FFP contains all the clotting factors and can help to correct the coagulopathy in a cirrhotic patient. This is especially important in a patient undergoing surgery, such as cholecystectomy, where bleeding is a major concern. The use of FFP can help to reduce the risk of bleeding and make the surgery safer.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not provided, so we cannot evaluate it.
**Option B:** This option is also not provided, so we cannot evaluate it.
**Option C:** This option is also not provided, so we cannot evaluate it.
**Clinical Pearl / High-Yield Fact**
In patients with cirrhosis, the risk of bleeding is high due to coagulopathy. This risk can be further increased by the use of anticoagulant medications, such as warfarin, and NSAIDs. Patients with cirrhosis should be carefully evaluated for coagulopathy before undergoing surgery and should receive appropriate treatment to correct any coagulopathy.
**Correct Answer: B. Transfusion of FFP is recommended in patients with cirrhosis undergoing non-emergency surgery to reduce the risk of bleeding.**